BRAF Mutant Gastrointestinal Stromal Tumor: First report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance-Reference-Cited by-同舟云学术

BRAF Mutant Gastrointestinal Stromal Tumor: First report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance

Published:2013-02-25 Issue:2 Volume:4 Page:310-315
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Falchook G.S.¹,Trent J.C.²,Heinrich M.C.³,Beadling C.³,Patterson J.³,Bastida C.C.¹,Blackman S.C.⁴,Kurzrock R.⁵

Affiliation:

1. Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

2. Sarcoma Medical Oncology Program, University of Miami, Sylvester Comprehensive Cancer Center, Miami, Florida

3. Portland VA Medical Center and Oregon Health & Science University (OHSU) Knight Cancer Institute, Division of Hematology & Oncology, Portland, Oregon

4. GlaxoSmithKline, Collegeville, PA

5. Moores Cancer Center, Department of Medicine, Hematology-Oncology Division, The University of California, San Diego, La Jolla, CA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal tumours of the small intestine;Morson and Dawson's Gastrointestinal Pathology;2024-08-30

2. Rapid but nondurable response of a BRAF exon 15 double-mutated spindle cell sarcoma to a combination of BRAF and MEK inhibitors;Oncotarget;2024-07-17

3. Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors;Cancers;2024-04-27

4. Treatment of BRAF V600E mutant gastrointestinal stromal tumor with dabrafenib: a case report;Journal of Gastrointestinal Oncology;2024-04

5. Role and Function of Receptor Tyrosine Kinases in BRAF Mutant Cancers;Receptors;2024-03-04